SCHEMBL3947734

SCHEMBL3947734

CC1(O)CCCN(C(=O)O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 1/20 0.37
EPHX2 P34913 4/20 0.33
CYP3A4 P08684 4/20 0.33
GRM5 P41594 2/20 0.33
HIF1A Q16665 1/20 0.33
KMT2A Q03164 3/20 0.33
CYP2C9 P11712 3/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
CYP2C19 P33261 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
USP2 O75604 1/20 0.32
TSHR P16473 3/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2D6 P10635 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
POLB P06746 1/20 0.31
HSPA1A P0DMV8 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1936290 0.87 FFAR3 (0.33) VNN1CYP3A4CYP2C9ALDH1A1CYP2C19
SCHEMBL4550437 0.83 CYP3A4 (0.43) VNN1EPHX2CYP3A4HIF1AKMT2A
SCHEMBL15516069 0.83 ALDH1A1 (0.44) EPHX2CYP3A4GRM5HIF1AKMT2A
SCHEMBL30728778 0.79 POLB (0.48) VNN1EPHX2CYP3A4CYP2C9ALDH1A1
SCHEMBL12895649 0.79 CYP2C9 (0.51) CYP3A4HIF1ACYP2C9ALDH1A1CYP2C19
SCHEMBL22991226 0.79 RIPK1 (0.38) VNN1EPHX2CYP3A4GRM5KMT2A
SCHEMBL16750122 0.79 VNN1 (0.38) VNN1GRM5KMT2ACYP2C9MEN1
SCHEMBL16975458 0.78 GRM5 (0.35) CYP3A4GRM5HIF1AKMT2AMEN1
SCHEMBL25269622 0.78 FFAR3 (0.44) EPHX2CYP3A4GRM5HIF1AKMT2A
SCHEMBL25268918 0.78 FFAR3 (0.44) EPHX2CYP3A4GRM5HIF1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118772151-A Compounds with anti-KRAS mutant tumor activity 泰励生物科技(上海)有限公司 2024-10-15 CN disclosed
CN-117769554-A Small molecule inhibitors of KRAS muteins 大鹏药品工业株式会社 2024-03-26 CN disclosed
CN-117624170-A Compounds with anti-KRAS mutant tumor activity 泰励生物科技(上海)有限公司 2024-03-01 CN disclosed
WO-2024012519-A1 PAN-KRAS INHIBITOR 北京华森英诺生物科技有限公司 2024-01-18 WO disclosed
WO-2009016410-A2 CHEMICAL COMPOUNDS 831 ASTRAZENECA AB (SE) 2009-02-05 WO disclosed